REQUEST A DEMO
Total
USD $0.00
Search more companies

Polimed Ilac Ve Tavukculuk Tic. Ve San. Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Polimed Ilac Ve Tavukculuk Ticaret Ve Sanayi Limited Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Polimed İlaç ve Tavukçuluk is a pharmaceutical company that claims to be a leader in many products. They promote and market their products in domestic and external markets with a focus on customer satisfaction.

Headquarters
Dap Teras Kule D:124 No:95 Topselvi Mahallesi Topselvi Caddesi Kartal
Istanbul; Marmara; Postal Code: 34873

Contact Details: Purchase the Polimed Ilac Ve Tavukculuk Tic. Ve San. Ltd. Sti. report to view the information.

Website: http://www.polimed.com.tr

Basic Information
Total Employees:
Purchase the Polimed Ilac Ve Tavukculuk Tic. Ve San. Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Polimed Ilac Ve Tavukculuk Tic. Ve San. Ltd. Sti. report to view the information.
Incorporation Date:
November 03, 1995
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Polimed Ilac Ve Tavukculuk Tic. Ve San. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
64.8%
Total operating revenue
64.8%
Operating profit (EBIT)
-33.97%
Net Profit (Loss) for the Period
9.64%
Total Assets
78.53%
Total Equity
82.81%
Operating Profit Margin (ROS)
-6.32%
Net Profit Margin
-3.53%
Return on Equity (ROE)
-10.06%
Debt/Equity
-8.96%
Quick Ratio
-0.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?